Hyperuricemia might promote thrombosis in essential thrombocythemia and polycythemia vera

被引：11
|
作者：
Krecak, Ivan [1 ]
Lucijanic, Marko [2 ]
Gveric-Krecak, Velka [1 ]
Durakovic, Nadira [3 ,4 ]
机构：
[1] Gen Hosp Sibenik Knin Cty, Dept Internal Med, Stjepana Radica 83, Shibenik 22000, Croatia
[2] Univ Hosp Dubrava, Dept Internal Med, Div Hematol, Zagreb, Croatia
[3] Univ Hosp Ctr Zagreb, Dept Internal Med, Div Hematol, Zagreb, Croatia
[4] Univ Zagreb, Sch Med, Zagreb, Croatia
来源：
LEUKEMIA & LYMPHOMA | 2020年 / 61卷 / 07期
关键词：
SERUM URIC-ACID; MYELOPROLIFERATIVE NEOPLASMS; CARDIOVASCULAR-DISEASE; MUTATIONS; RISK; GOUT;
D O I：
10.1080/10428194.2020.1731503
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1744 / 1747
页数：4
相关论文
共 50 条
  • [41] Oral anticoagulant therapy for the prevention of recurrent thrombosis in patients with polycythemia vera or essential thrombocythemia
    Arellano-Rodrigo, E.
    Hernandez-Boluda, J. C.
    Cervantes, F.
    Alvarez-Larran, A.
    Gomez, M.
    Barba, P.
    Mata, M., I
    Gonzalez-Porras, J. R.
    Ferrer-Marin, F.
    Garcia-Gutierrez, V
    Magro, E.
    Moreno, M.
    Kerguelen, A.
    Perez-Encinas, M.
    Estrada, N.
    Ayala, R.
    Besses, C.
    Pereira, A.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 683 - 683
  • [42] Chronic kidney disease could be a risk factor for thrombosis in essential thrombocythemia and polycythemia vera
    Krecak, Ivan
    Holik, Hrvoje
    Martina, Moric Peric
    Zekanovic, Ivan
    Coha, Bozena
    Gveric-Krecak, Velka
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2020, 112 (03) : 377 - 384
  • [43] New and treatment-relevant risk stratification for thrombosis in essential thrombocythemia and polycythemia vera
    Tefferi, Ayalew
    Barbui, Tiziano
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (08) : 683 - 685
  • [44] Treatment of polycythemia vera and essential thrombocythemia: The role of Pipobroman
    Passamonti, F
    Lazzarino, M
    [J]. LEUKEMIA & LYMPHOMA, 2003, 44 (09) : 1483 - 1488
  • [45] Interferon-α therapy in polycythemia vera and essential thrombocythemia
    Elliott, MA
    Tefferi, A
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1997, 23 (05): : 463 - 472
  • [46] THROMBOEMBOLISM PREDICTIVE FACTORS IN POLYCYTHEMIA VERA AND ESSENTIAL THROMBOCYTHEMIA
    Bellora, A.
    Tamiazzo, S.
    Primon, V.
    Pini, M.
    Corsetti, M. T.
    Cornaglia, E.
    Demichelis, M.
    Santi, R.
    Contino, L.
    Levis, A.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 410 - 410
  • [47] RESULTS of Allogeneic TRANSPLANTATION for Polycythemia VERA and Essential Thrombocythemia
    Ballen, Karen K.
    Arora, Mukta
    Zhu, Xiaochun
    Agovi, Manza
    Kalaycio, Matt
    Maziarz, Richard T.
    Cortes, Jorge E.
    Woolfrey, Ann
    Horowitz, Mary M.
    Saber, Wael
    [J]. BLOOD, 2010, 116 (21) : 1444 - 1445
  • [48] Venous thromboembolism in patients with essential thrombocythemia and polycythemia vera
    Reikvam, H.
    Tiu, R. V.
    [J]. LEUKEMIA, 2012, 26 (04) : 563 - 571
  • [49] Epidemiology of the myeloproliferative disorders polycythemia vera and essential thrombocythemia
    Johansson, P
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2006, 32 (03): : 171 - 173
  • [50] Essential Thrombocythemia and Polycythemia Vera: Focus on Clinical Practice
    Tefferi, Ayalew
    Barbui, Tiziano
    [J]. MAYO CLINIC PROCEEDINGS, 2015, 90 (09) : 1283 - 1293
12345